A Double Blind, Randomized, Placebo Controlled, Dose Escalation Study To Investigate The Pharmacokinetics (In The Fed And Fasted State), Safety And Toleration Of Single Oral Doses Of PF-04634817 In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 12 Oct 2010
At a glance
- Drugs PF 4634817 (Primary)
- Indications Viral infections
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 12 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Sep 2010 Planned end date changed from 1 Aug 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.
- 03 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.